Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cannon

Showing results (41-50 of 308) with videos related to

Pageof 31
Sort By:
American Journal of Human Genetics|November 3, 2018
Deciphering the Emerging Complexities of Molecular Mechanisms at GWAS LociMaren E Cannon, Karen L Mohlke
Circulation|October 5, 2016
Response by Cannon and Pepke-Zaba to Letter Regarding Article, "Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort"John E Cannon, Joanna Pepke-Zaba
Current Opinion in Cardiology|April 7, 1999
Current therapies for secondary prevention after myocardial infarctionC E Cannon, S C Smith
Applied and Environmental Microbiology|October 1, 1989
Alternative Environmental Roles for Cellulose Produced by Acetobacter xylinumW S Williams, R E Cannon
Parasitology|October 1, 1970
Changes in the chemical composition of Hymenolepis diminuta (Cestoda: Cyclophyllidea) during prepatent development within the rat intestineD F Mettrick, C E Cannon
Expert Review of Clinical Pharmacology|March 4, 2014
Riociguat for pulmonary hypertensionJohn E Cannon, Joanna Pepke-Zaba
Nature Biotechnology|January 7, 1998
Shock toxicology with transgenicsR E Cannon, R W Tennant
The Journal of Pain|March 18, 2005
Inhibition of chemical and low-intensity mechanical nociception by activation of histamine H3 receptorsKeri E Cannon, Lindsay B Hough
Seminars in Respiratory and Critical Care Medicine|September 17, 2013
Is distal chronic thromboembolic pulmonary hypertension treatable with PAH targeted drugs?J E Cannon, J Pepke-Zaba
Trends in Plant Science|January 20, 2021
Lipid Signaling through G ProteinsAshley E Cannon, Kent D Chapman
Pageof 31

Showing results (41-50 of 308) with videos related to

Sort By:
Pageof 31
American Journal of Human Genetics|November 3, 2018
Deciphering the Emerging Complexities of Molecular Mechanisms at GWAS LociMaren E Cannon, Karen L Mohlke
Circulation|October 5, 2016
Response by Cannon and Pepke-Zaba to Letter Regarding Article, "Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort"John E Cannon, Joanna Pepke-Zaba
Current Opinion in Cardiology|April 7, 1999
Current therapies for secondary prevention after myocardial infarctionC E Cannon, S C Smith
Applied and Environmental Microbiology|October 1, 1989
Alternative Environmental Roles for Cellulose Produced by Acetobacter xylinumW S Williams, R E Cannon
Parasitology|October 1, 1970
Changes in the chemical composition of Hymenolepis diminuta (Cestoda: Cyclophyllidea) during prepatent development within the rat intestineD F Mettrick, C E Cannon
Expert Review of Clinical Pharmacology|March 4, 2014
Riociguat for pulmonary hypertensionJohn E Cannon, Joanna Pepke-Zaba
Nature Biotechnology|January 7, 1998
Shock toxicology with transgenicsR E Cannon, R W Tennant
The Journal of Pain|March 18, 2005
Inhibition of chemical and low-intensity mechanical nociception by activation of histamine H3 receptorsKeri E Cannon, Lindsay B Hough
Seminars in Respiratory and Critical Care Medicine|September 17, 2013
Is distal chronic thromboembolic pulmonary hypertension treatable with PAH targeted drugs?J E Cannon, J Pepke-Zaba
Trends in Plant Science|January 20, 2021
Lipid Signaling through G ProteinsAshley E Cannon, Kent D Chapman
Pageof 31